Education
About Us
Working with TipRanks
Follow Us
Pliant Therapeutics (PLRX)
NASDAQ:PLRX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 1.58M | $ 9.69M | $ 7.57M | $ 41.82M |
| Gross Profit | $ 0.00 | $ 1.58M | $ 9.69M | $ 7.57M | $ 41.82M |
| Operating Income | $ -228.37M | $ -184.15M | $ -127.20M | $ -97.53M | $ -41.65M |
| EBITDA | $ -205.16M | $ -158.23M | $ -118.85M | $ -95.73M | $ -40.34M |
| Net Income | $ -210.30M | $ -161.34M | $ -123.32M | $ -97.26M | $ -41.53M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 355.72M | $ 494.25M | $ 331.19M | $ 200.60M | $ 276.89M |
| Total Assets | $ 396.95M | $ 512.15M | $ 350.61M | $ 221.22M | $ 295.53M |
| Total Debt | $ 60.19M | $ 11.37M | $ 15.81M | $ 7.19M | $ 0.00 |
| Net Debt | $ -11.00M | $ -51.86M | $ -17.87M | $ -44.47M | $ -50.88M |
| Total Liabilities | $ 92.87M | $ 38.58M | $ 37.27M | $ 22.16M | $ 12.46M |
| Stockholders' Equity | $ 304.08M | $ 473.58M | $ 313.34M | $ 199.06M | $ 283.06M |
| Cash Flow | |||||
| Free Cash Flow | $ -159.35M | $ -117.28M | $ -96.39M | $ -77.40M | $ -38.80M |
| Operating Cash Flow | $ -155.50M | $ -116.36M | $ -94.63M | $ -75.44M | $ -37.27M |
| Investing Cash Flow | $ 140.34M | $ -127.01M | $ -150.20M | $ 73.70M | $ -210.87M |
| Financing Cash Flow | $ 23.12M | $ 274.40M | $ 226.85M | $ 2.53M | $ 213.21M |